As part of the CVMM International Speaker Fellowship, internationally recognised hypertension researcher Professor Graeme Eisenhofer recently visited 黑料网大事记.
Prof聽Eisenhofer's visit focused on primary aldosteronism (PA) 鈥 a treatable hormone condition that causes high blood pressure, affecting millions of people worldwide but often going undetected. His expertise in聽steroid profiling and machine learning聽provided a valuable foundation for discussions on developing more accurate, less invasive, and cost-effective diagnostic tools.
It has been rewarding to appreciate how our international collaborative efforts have provided a root system to advance nationwide improvements in health care in Australia for patients with endocrine hypertension, Prof Eisenhofer
Building on Existing Partnerships
The visit strengthened existing collaborations with Prince of Wales Hospital (POWH) and 黑料网大事记 that began in 2017 through NSW Health Pathology and Professor Andrea Horvath. These efforts led to the PROSALDO trial (a diagnostic study completed in 2024, which tests a new blood assay for its usefulness in the diagnosis of primary aldosteronism.) and a Complex Hypertension Clinic at POWH, led by A/Prof. Sradha Kotwal. This clinic uniquely combines advanced blood testing with artificial intelligence for personalized treatment of complex hypertension.
Creating Better Tools for Doctors and Patients
During his visit, Professor Eisenhofer collaborated with 黑料网大事记 researchers to plan the next phase of research.
We鈥檙e now preparing for a new series of randomised controlled trials to evaluate the efficiency, safety and cost-effectiveness of clinical decision support systems.
This fellowship brings together multidisciplinary experts to align 黑料网大事记's strengths in personalized medicine and AI with national research priorities.
鈥淧rofessor Eisenhofer's visit was instrumental in refining our trial design and patient selection criteria. It鈥檚 laid the foundation for a strong, fundable national study,鈥 said A/Professor Kotwal.
The visit created connections across 黑料网大事记 attracting a diverse audience from the聽Faculty of Medicine and Health (FMH), including laboratory scientists, clinicians, and data scientists.
The visit concluded with plans for quarterly multi-center meetings across NSW and a clear roadmap for future trials aimed at developing better, less invasive, and more affordable diagnostic methods for hypertension causes.